Modalis Therapeutics Corporation (4883.T)

JPY 103.0

(-1.9%)

Total Debt Summary of Modalis Therapeutics Corporation

  • Modalis Therapeutics Corporation's latest annual total debt in 2023 was 412.5 Million JPY , down 0.0% from previous year.
  • Modalis Therapeutics Corporation's latest quarterly total debt in 2024 Q2 was 162.5 Million JPY , down -55.17% from previous quarter.
  • Modalis Therapeutics Corporation reported annual total debt of - JPY in 2022, down 0.0% from previous year.
  • Modalis Therapeutics Corporation reported annual total debt of - JPY in 2021, down 0.0% from previous year.
  • Modalis Therapeutics Corporation reported quarterly total debt of 162.5 Million JPY for 2024 Q2, down -55.17% from previous quarter.
  • Modalis Therapeutics Corporation reported quarterly total debt of 412.5 Million JPY for 2023 FY, down 0.0% from previous quarter.

Annual Total Debt Chart of Modalis Therapeutics Corporation (2023 - 2019)

Historical Annual Total Debt of Modalis Therapeutics Corporation (2023 - 2019)

Year Total Debt Total Debt Growth
2023 412.5 Million JPY 0.0%
2022 - JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%

Peer Total Debt Comparison of Modalis Therapeutics Corporation

Name Total Debt Total Debt Difference
Pharma Foods International Co., Ltd. 16.89 Billion JPY 97.558%
Takeda Pharmaceutical Company Limited 4843.75 Billion JPY 99.991%
Sumitomo Pharma Co., Ltd. 418.88 Billion JPY 99.902%
Shionogi & Co., Ltd. 11.62 Billion JPY 96.45%
Wakamoto Pharmaceutical Co.,Ltd. 100.52 Million JPY -310.329%
Nippon Shinyaku Co., Ltd. 2.87 Billion JPY 85.637%
Kaken Pharmaceutical Co., Ltd. 3.85 Billion JPY 89.286%
Eisai Co., Ltd. 206.74 Billion JPY 99.8%
Morishita Jintan Co., Ltd. 425 Million JPY 2.941%
Hisamitsu Pharmaceutical Co., Inc. 2.1 Billion JPY 80.357%
Mochida Pharmaceutical Co., Ltd. 369 Million JPY -11.789%
Fuso Pharmaceutical Industries,Ltd. 12.72 Billion JPY 96.758%
Nippon Chemiphar Co., Ltd. 16.98 Billion JPY 97.571%
Tsumura & Co. 79.69 Billion JPY 99.482%
Kissei Pharmaceutical Co., Ltd. 1.72 Billion JPY 76.115%
Torii Pharmaceutical Co., Ltd. 244 Million JPY -69.057%
Towa Pharmaceutical Co., Ltd. 202.35 Billion JPY 99.796%
Fuji Pharma Co., Ltd. 28.94 Billion JPY 98.575%
Zeria Pharmaceutical Co., Ltd. 47.58 Billion JPY 99.133%
KYORIN Holdings, Inc. 20.94 Billion JPY 98.031%
Taiko Pharmaceutical Co.,Ltd. 3.8 Billion JPY 89.17%
Daito Pharmaceutical Co.,Ltd. 8.71 Billion JPY 95.269%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 60 Million JPY -587.5%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.48 Billion JPY 95.651%
Sawai Group Holdings Co., Ltd. 82.89 Billion JPY 99.502%
Cyfuse Biomedical K.K. 913 Million JPY 54.819%
Toho Holdings Co., Ltd. 30.24 Billion JPY 98.636%
Koa Shoji Holdings Co.,Ltd. 2.82 Billion JPY 85.4%